[Effectiveness of bisphosphonate administration for prevention of osteopenia during Gn-RH agonist therapy of endometriosis].
Aisaka
Kohzo
K
Department of Obstetrics and Gynecology, Odaira Memorial Tokyo Hitachi Hospital.
D015519:Bone Density; D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D001851:Bone Diseases, Metabolic / Q000378:metabolism / Q000517:prevention & control*; D004164:Diphosphonates / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D004715:Endometriosis / Q000188:drug therapy*; D004967:Estrogens / Q000008:administration & dosage; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D011374:Progesterone
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D004967:Estrogens; D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone